RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.

Related Reports

Market Research Reports provided by reports.iptechex.com
Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis
Mar 2011 - 4 pages - $500
The Cat Rental Store - Company Capsule
Aug 2011 - 8 pages - $75
Black Cat Engineering & Construction W.L.L - Company Capsule
Nov 2011 - 7 pages - $75
Liver Fibrosis Global Clinical Trials Review, Q1, 2011
Apr 2011 - 57 pages - $1,000
Saratoga Hospital - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Royal United Hospital Bath NHS Trust - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Cat care in North America to 2013
Jul 2009 - 95 pages - $495
Liver Fibrosis Global Clinical Trials Review, H2, 2011
Sep 2011 - 83 pages - $1,000
Cat care in Latin America to 2013
Jul 2009 - 89 pages - $495
Cat care in Eastern Europe to 2013
Jul 2009 - 95 pages - $495
More Related Market Research Reports >>>

Your selection

Industry sector
Diagnostic del
CAT del
Therapeutic target
Hospital and Surgery del
Fibrosis del

Browse By

Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us